Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Fresh Wind Biotechnologies USA
AddedFeb 17, 2024
UpdatedJun 18, 2026
Fresh Wind Biotechnologies USA

Fresh Wind Biotechnologies USA

Series A

Specializing in cellular immunotherapy, we engineer immune systems using genomic data to cure cancers.

HQ
Houston, TX, US
Founded
2020
Overview
Compare
Fundraising
Employees
Website

Fresh Wind Biotechnologies USA was founded by a group of PhD students from Baylor College of Medicine with the mission to improve cancer patient outcomes. The company specializes in cellular immunotherapy, leveraging genomic and proteomic data to engineer immune systems specifically designed to cure cancers. Their core vision is to translate cutting-edge innovations into curative clinical actions, offering personalized therapies that are both effective and safe for cancer patients.

Notable affiliated individuals include experienced scientists, investors, and entrepreneurs who have collectively advanced the company's mission. Fresh Wind Biotechnologies has achieved significant milestones in the field of personalized cancer treatment through its innovative approach. The impact of their work is evident in the promising advancements in cellular immunotherapy, contributing to the broader goal of curing cancer through personalized medical solutions.

Fresh Wind Biotechnologies USA - Similar Companies

Geneius logo

Geneius

geneius.com

Cell BioEngines logo

Cell BioEngines

cellbioengines.com

ImmunoGenesis logo

ImmunoGenesis

immunogenesis.com

RootPath Genomics logo

RootPath Genomics

rootpath.com

Tradewind BioScience logo

Tradewind BioScience

tradewindbio.com

Guardian Bio logo

Guardian Bio

guardian-bio.com

Cartography Biosciences logo

Cartography Biosciences

cartography.bio

Thunder Biotech logo

Thunder Biotech

thunderbiotech.com

Immunitas Therapeutics logo

Immunitas Therapeutics

immunitastx.com

Mongoose Bio logo

Mongoose Bio

mongoosebio.com

Engage Bio logo

Engage Bio

Appia Bio logo

Appia Bio

appiabio.com

Window Therapeutics logo

Window Therapeutics

windowtx.com

Immpact Bio logo

Immpact Bio

immpact-bio.com

Fore Biotherapeutics logo

Fore Biotherapeutics

fore.bio

Fresh Wind Biotechnologies USA - Quick Facts

Who are Fresh Wind Biotechnologies USA's competitors?

Companies similar to Fresh Wind Biotechnologies USA include Geneius, Cell BioEngines, ImmunoGenesis and RootPath Genomics.

When was Fresh Wind Biotechnologies USA founded?

Fresh Wind Biotechnologies USA was founded in 2020.

Where is Fresh Wind Biotechnologies USA's headquarters located?

Fresh Wind Biotechnologies USA's headquarters is located in Houston, TX, US.

When was Fresh Wind Biotechnologies USA's last funding round?

Fresh Wind Biotechnologies USA's most recent funding round was for $10M (USD) in June 2021.

How much has Fresh Wind Biotechnologies USA raised to-date?

As of Jun 28, 2021, Fresh Wind Biotechnologies USA has raised a total of $10M (USD).

How many employees does Fresh Wind Biotechnologies USA have?

Fresh Wind Biotechnologies USA has 11 employees as of Feb 4, 2024.

Fresh Wind Biotechnologies USA - Classification

Ownership
  • Venture Capital
Technology
  • AI
  • Biotech
Geographic Exposure
  • United States
Model
  • Platform
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Cancer Therapies
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software